Thus, loss of HSV-1 ICP22 appears to delay the peak response of CD4+ immune cell infiltrates and matched effector cell populations in KOS infection, resulting in no differences in eye disease pathology between ICP22 null– and KOS-infected mice groups. Here, CD4 is linked to eye disorder.